These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 17513311)

  • 41. Pathway aggregation for survival prediction via multiple kernel learning.
    Sinnott JA; Cai T
    Stat Med; 2018 Jul; 37(16):2501-2515. PubMed ID: 29664143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IPI59: An Actionable Biomarker to Improve Treatment Response in Serous Ovarian Carcinoma Patients.
    Choi J; Ye S; Eng KH; Korthauer K; Bradley WH; Rader JS; Kendziorski C
    Stat Biosci; 2017 Jun; 9(1):1-12. PubMed ID: 28966695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel procedure for statistical inference and verification of gene regulatory subnetwork.
    Gong H; Klinger J; Damazyn K; Li X; Huang S
    BMC Bioinformatics; 2015; 16 Suppl 7(Suppl 7):S7. PubMed ID: 25952938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathway-gene identification for pancreatic cancer survival via doubly regularized Cox regression.
    Gong H; Wu TT; Clarke EM
    BMC Syst Biol; 2014; 8 Suppl 1(Suppl 1):S3. PubMed ID: 24565114
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SBERIA: set-based gene-environment interaction test for rare and common variants in complex diseases.
    Jiao S; Hsu L; Bézieau S; Brenner H; Chan AT; Chang-Claude J; Le Marchand L; Lemire M; Newcomb PA; Slattery ML; Peters U
    Genet Epidemiol; 2013 Jul; 37(5):452-64. PubMed ID: 23720162
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathway index models for construction of patient-specific risk profiles.
    Eng KH; Wang S; Bradley WH; Rader JS; Kendziorski C
    Stat Med; 2013 Apr; 32(9):1524-35. PubMed ID: 23074142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bayesian gene set analysis for identifying significant biological pathways.
    Shahbaba B; Tibshirani R; Shachaf CM; Plevritis SK
    J R Stat Soc Ser C Appl Stat; 2011 Aug; 60(4):541-557. PubMed ID: 21857748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studying gene and gene-environment effects of uncommon and common variants on continuous traits: a marker-set approach using gene-trait similarity regression.
    Tzeng JY; Zhang D; Pongpanich M; Smith C; McCarthy MI; Sale MM; Worrall BB; Hsu FC; Thomas DC; Sullivan PF
    Am J Hum Genet; 2011 Aug; 89(2):277-88. PubMed ID: 21835306
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Confounded by sequencing depth in association studies of rare alleles.
    Garner C
    Genet Epidemiol; 2011 May; 35(4):261-8. PubMed ID: 21328616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statistical analysis strategies for association studies involving rare variants.
    Bansal V; Libiger O; Torkamani A; Schork NJ
    Nat Rev Genet; 2010 Nov; 11(11):773-85. PubMed ID: 20940738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Buckley-James boosting for survival analysis with high-dimensional biomarker data.
    Wang Z; Wang CY
    Stat Appl Genet Mol Biol; 2010; 9(1):Article24. PubMed ID: 20597850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incorporating pathway information into boosting estimation of high-dimensional risk prediction models.
    Binder H; Schumacher M
    BMC Bioinformatics; 2009 Jan; 10():18. PubMed ID: 19144132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gene module level analysis: identification to networks and dynamics.
    Wang X; Dalkic E; Wu M; Chan C
    Curr Opin Biotechnol; 2008 Oct; 19(5):482-91. PubMed ID: 18725293
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Markov random field model for network-based analysis of genomic data.
    Wei Z; Li H
    Bioinformatics; 2007 Jun; 23(12):1537-44. PubMed ID: 17483504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
    Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
    Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer.
    Decock J; Paridaens R; Ye S
    Clin Genet; 2008 Mar; 73(3):197-211. PubMed ID: 18177467
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Group additive regression models for genomic data analysis.
    Luan Y; Li H
    Biostatistics; 2008 Jan; 9(1):100-13. PubMed ID: 17513311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonparametric pathway-based regression models for analysis of genomic data.
    Wei Z; Li H
    Biostatistics; 2007 Apr; 8(2):265-84. PubMed ID: 16772399
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.